Retatrutide is being investigated for metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), alongside obesity and type 2 diabetes
What Patients on Semaglutide Are Reporting Anecdotal reports from patients on semaglutide describe two distinct patterns that appear to depend heavily on timing
Killion EA, Wang J, Yie J et al (2018) Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
Konturek SJ, Czesnikiewicz-Guzik M
Hormones activated: GLP-1, GIP, PYY
For example, some parts of ADHD like staying organized or managing time well often need other strategies (like planners, reminders, or coaching) even with perfect medication